Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
FDA Approves G1 Therapeutics' Cosela to Prevent Chemo Damage in Lung Cancer
Nia JulianFebruary 15, 2021
Facebook0 Twitter Pinterest0 0 Likes
Previous

Arcellx Announces FDA Clearance of IND Application for ACLX-001, a Controllable Cell Therapy Utilizing the Company’s ARC-SparX Platform, for the Treatment of Multiple Myeloma

Nia JulianApril 7, 2021
Next

Molecular Templates Establishes Multi-Target Collaboration With Bristol Myers Squibb for the Discovery and Development of Next Generation Engineered Toxin Bodies for the Treatment of Cancer

Nia JulianFebruary 11, 2021

© 2020 Solasta Ventures. All Rights Reserved.